Target intelligence / Profile preview

Nematode glutamate-gated chloride channel (GluCl) (GluCl)

Target
GluCl
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family
01

Overview

The nematode glutamate-gated chloride channel (GluCl) is a member of the Cys-loop family of ligand-gated ion channels, found exclusively in invertebrates such as nematodes and arthropods [1]. These channels mediate fast inhibitory neurotransmission by allowing the influx of chloride ions upon activation by L-glutamate, leading to membrane hyperpolarization [2]. GluCls play critical roles in regulating nematode locomotion, feeding through pharyngeal pumping, and sensory input processing [3]. They are the primary molecular targets for the avermectin and milbemycin classes of anthelmintic drugs, most notably ivermectin [4]. By binding to the transmembrane domain of the channel, these drugs act as potent agonists or allosteric activators, causing prolonged channel opening [1, 2]. This persistent activation results in flaccid paralysis and eventual death of the parasite [1]. Because GluCls are absent in vertebrates, they provide a high margin of therapeutic safety for the host [4]. However, at high concentrations, these drugs can potentially interact with vertebrate GABA or glycine receptors [2]. Resistance to these drugs is an emerging concern, often linked to mutations in the GluCl subunits [1]. Understanding the structure and function of GluCl remains vital for developing new antiparasitic agents [2].

Other names
Glutamate-gated chloride channelGluCl receptorAvermectin-sensitive glutamate-gated chloride channelH-receptor
02

Mechanism of action

Drugs targeting this channel act as potent allosteric agonists or activators that bind to the transmembrane domain, stabilizing the open state of the channel and causing a persistent influx of chloride ions, which leads to hyperpolarization and flaccid paralysis of the parasite [1, 2, 4].

03

Biological functions

Inhibitory neurotransmissionLocomotionPharyngeal pumpingSensory processing
04

Disease associations

InfectionHelminthiasisOnchocerciasisLymphatic filariasisStrongyloidiasis
05

Safety considerations

Neurotoxicity in MDR1-deficient hostsDevelopment of anthelmintic resistancePotential off-target effects on vertebrate GABA-A or glycine receptors at high doses
06

Interacting drugs

Ivermectin

6 more in the full profile.

07

Biomarkers

Parasite microfilarial loadglc-1 gene mutationsavr-14 gene mutationsavr-15 gene mutations

Beyond the preview

Go deeper on Nematode glutamate-gated chloride channel (GluCl) (GluCl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nematode glutamate-gated chloride channel (GluCl) (GluCl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call